Stomatitis (Sore Mouth) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Stomatitis (Sore Mouth) – Drugs In Development, 2024 report and make more profitable business decisions.
Stomatitis is inflammation of the mouth and lips. It refers to any inflammatory process affecting the mucous membranes of the mouth and lips, with or without oral ulceration. The inflammation can be the result of conditions within the mouth itself, such as poor oral hygiene, poorly fitted dentures, or mouth burns from hot food or drinks. It may also be caused by conditions that affect the entire body, such as medications, allergic reactions, or infections. A form of stomatitis known as stomatitis nicotina can be caused by smoking cigars, cigarettes, and/or pipes, and is characterized by small red bumps on the roof of the mouth. Causes include Nutritional deficiency, Aphthous stomatitis, dentures, Allergic contact stomatitis etc.
The Stomatitis (Sore Mouth) drugs in development market research report provide comprehensive information on the therapeutics under development for Stomatitis (Sore Mouth), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Stomatitis (Sore Mouth) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Stomatitis (Sore Mouth) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 17 molecules, with 15 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Stomatitis (Sore Mouth) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Stomatitis (Sore Mouth) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Stomatitis (Sore Mouth) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Allander Biotechnologies LLCClevexel Pharma SA
Destiny Pharma Plc
EpicentRx Inc
GlycoMira Therapeutics Inc
iNtRON Biotechnology Inc
Maruho Co Ltd
Matrix Biomed Inc
MitoImmune Therapeutics Inc
Moberg Pharma AB
Sinopia Biosciences Inc
The Second Affiliated Hospital To Nanchang University
University of Arizona
VasoDynamics Ltd
Wellstat Therapeutics Corp
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Stomatitis (Sore Mouth) reports